LIfT BioSciences announces partnership with University of Galway for clinical trial in Ireland London, 28 April 2025- LIfT BioSciences, ('LIfT' or 'the Company'), a rapidly emerging biotech and the ...

A recent report in The Times of India reveals that Roche may have profited immensely from risdiplam, a drug for spinal ...

Immunic's lead asset, vidofludimus calcium, shows promise in MS trials, with positive interim results. See why I rate IMUX ...

While technology may continue to be an excellent investment and repeat its outstanding returns of the past five years, the recent short-term sell-off flags the possibility of a significant slump and ...